We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Quinolactacin Biosynthesis Involves Non‐Ribosomal‐Peptide‐Synthetase‐Catalyzed Dieckmann Condensation to Form the Quinolone‐γ‐lactam Hybrid.
- Authors
Zhao, Fanglong; Liu, Zhiwen; Yang, Shuyuan; Ding, Ning; Gao, Xue
- Abstract
Quinolactacins are novel fungal alkaloids that feature a quinolone‐γ‐lactam hybrid, which is a potential pharmacophore for the treatment of cancer and Alzheimer's disease. Herein, we report the identification of the quinolactacin A2 biosynthetic gene cluster and elucidate the enzymatic basis for the formation of the quinolone‐γ‐lactam structure. We reveal an unusual β‐keto acid (N‐methyl‐2‐aminobenzoylacetate) precursor that is derived from the primary metabolite l‐kynurenine via methylation, oxidative decarboxylation, and amide hydrolysis reactions. In vitro assays reveal two single‐module non‐ribosomal peptide synthetases (NRPs) that incorporate the β‐keto acid and l‐isoleucine, followed by Dieckmann condensation, to form the quinolone‐γ‐lactam. Notably, the bioconversion from l‐kynurenine to the β‐keto acid is a unique strategy employed by nature to decouple R*‐domain‐containing NRPS from the polyketide synthase (PKS) machinery, expanding the paradigm for the biosynthesis of quinolone‐γ‐lactam natural products via Dieckmann condensation.
- Subjects
CONDENSATION; LIGASES; NATURAL products; ALZHEIMER'S disease; GENE clusters; BETA lactam antibiotics; BIOSYNTHESIS; BIOCONVERSION
- Publication
Angewandte Chemie, 2020, Vol 132, Issue 43, p19270
- ISSN
0044-8249
- Publication type
Academic Journal
- DOI
10.1002/ange.202005770